Developing countries get $12bn World Bank support for COVID-19 vaccines

The executive board of the World Bank has approved $12bn in new funding for developing countries to finance the purchase and distribution of Covid-19 vaccines, tests, and treatments for their citizens.

The financing plan is part of a $160bn in total resources that the multilateral development lender has pledged to provide to developing countries through June 2021 to help fight the coronavirus pandemic.

The World Bank said the financing programme will also include technical support to recipient countries so they can prepare for deploying vaccines at scale.

It is also to signal to drug companies that there will be strong demand and ample financing for Covid-19 vaccines in developing countries.

‘This financing package helps signal to the research and pharmaceutical industry that citizens in developing countries also need access to safe and effective Covid-19 vaccines,’ the bank said in a statement.

‘It will also provide financing and technical support so that developing countries can prepare for deploying vaccines at scale, in coordination with international partners.’

Access to safe and effective vaccines ‘and strengthened delivery systems is key to alter the course of the pandemic and help countries experiencing catastrophic economic and fiscal impacts move toward a resilient recovery,’ World Bank Group President David Malpass said in the statement.

The financing ‘will also support countries to expand immunisation capacity to help health systems deploy the vaccines effectively,’ the statement added.

The financing approval was expected as Mr Malpass had announced the project in late September.

While vaccines are yet to appear on the market, Mr. Malpass noted in an interview with the French daily Le Figaro that it was necessary to prepare because of the complicated vaccine distribution process.

The Bank’s approach, according to the statement, draws on its ‘significant expertise in supporting large scale immunisation programs for vaccine-preventable diseases, as well as public health programs to tackle infectious diseases such as HIV, tuberculosis, malaria and neglected tropical diseases.’

By Jamila Akweley Okertchiri

ABOUT: Nana Kwesi Coomson

[email protected]

An Entrepreneur, Corporate Social Responsibility, Corporate Communications Executive and Philanthropist. Editor-in-Chief of www.233times.com. A Senior Journalist with Ghanaian Chronicle Newspaper. An alumnus of Adisadel College where he read General Arts. His first degree is in Bachelor of Arts - Political Science (major) and History (minor) from the University of Ghana. He holds MSc in Corporate Social Responsibility (CSR) and Energy with Public Relations (PR) from the Robert Gordon University in the United Kingdom. He is a 2018 Mandela Washington Fellow who studied at Clark Atlanta University in USA on the Business and Entrepreneurship track.

View all posts by: Nana Kwesi Coomson  

Leave a Reply

Your email address will not be published. Required fields are marked *

ABOUT 233TIMES

233times is a Ghanaian media house which serves as a major source of exclusive interviews ,music and video downloads, news and more.

233times reports on major events,news covering entertainment, politics, sports, business, technology, etc from within Ghana, Africa and beyond.

We have a platform for the amateur artistes to portray their staggering talents ...more...

CONTACT US

For further enquiries, please contact us via our contact us page link: CONTACT

WE ON SOCIAL MEDIA. FOLLOW US


To advertise with us or make enquiries, please visit 233times.net/advertise or call Selorm (Selorm) | Selorm (Nana Kwesi)